Growth Metrics

Evolent Health (EVH) Accounts Payables (2016 - 2026)

Evolent Health has reported Accounts Payables over the past 11 years, most recently at $59.8 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 37.75% year-over-year to $59.8 million; the TTM value through Dec 2025 reached $59.8 million, down 37.75%, while the annual FY2025 figure was $59.8 million, 37.75% down from the prior year.
  • Accounts Payables for Q4 2025 was $59.8 million at Evolent Health, down from $72.2 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $96.6 million in Q2 2022 and troughed at $37.8 million in Q3 2021.
  • A 5-year average of $64.1 million and a median of $60.8 million in 2022 define the central range for Accounts Payables.
  • Biggest five-year swings in Accounts Payables: soared 200.5% in 2021 and later tumbled 49.28% in 2024.
  • Year by year, Accounts Payables stood at $96.1 million in 2021, then tumbled by 40.5% to $57.2 million in 2022, then dropped by 15.62% to $48.2 million in 2023, then soared by 99.03% to $96.0 million in 2024, then plummeted by 37.75% to $59.8 million in 2025.
  • Business Quant data shows Accounts Payables for EVH at $59.8 million in Q4 2025, $72.2 million in Q3 2025, and $69.5 million in Q2 2025.